| Literature DB >> 35428632 |
Chia-Wen Hsu1, Bao-Bao Hsu2, Malcolm Koo3,4, Ming-Chi Lu5,2,6.
Abstract
OBJECTIVE: The aim of this study was to investigate the association of demographic factors, clinical manifestations and disease activity of systemic lupus erythematosus (SLE) with intimate relationships in female patients with SLE.Entities:
Keywords: disease activity; intimacy; quality of life; systemic lupus erythematosus
Mesh:
Year: 2022 PMID: 35428632 PMCID: PMC9014030 DOI: 10.1136/bmjopen-2021-055754
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 3.006
Baseline characteristics of the study participants (N=243)
| Variable | n (%) |
| Age interval (years) | |
| ≥40 | 146 (60.1) |
| 20‒39 | 97 (39.9) |
| Body mass index (kg/m2) | |
| Normal (≥18.5 and <24.0) | 127 (52.3) |
| Other | 116 (47.7) |
| Educational level | |
| High school or below | 121 (49.8) |
| College or above | 122 (50.2) |
| Marital status | |
| Married | 168 (69.1) |
| Single, widowed, divorced | 75 (30.9) |
| Employment status | |
| Unemployed | 80 (32.9) |
| Employed | 163 (67.1) |
| Job change related to SLE | 69 (28.4) |
| Self-reported health status | |
| Not healthy | 175 (72.0) |
| Healthy | 68 (28.0) |
| Smoking habit | 18 (7.4) |
| Alcohol use | 59 (24.3) |
| Regular exercise | 204 (84.0) |
| Length of sleep, hours | |
| ≤7 | 204 (84.0) |
| ≥8 | 39 (16.0) |
| Sleeping medication use | 66 (27.2) |
| Age at diagnosis, years | |
| ≥30 | 105 (43.2) |
| ≤29 | 138 (56.8) |
| Disease duration, years | |
| ≥10 | 163 (67.1) |
| ≤9 | 80 (32.9) |
| SLE-DAS (median, IQR) | 2.08 (1.12, 7.23) |
| Arthritis | 54 (22.2) |
| Malar rash | 31 (12.8) |
| Photosensitivity | 118 (48.6) |
| Discoid rash | 2 (0.8) |
| Alopecia | 28 (11.5) |
| Oral ulcer | 32 (13.2) |
| Vasculitis, skin | 7 (2.9) |
| Sjögren’s syndrome | 64 (26.3) |
| Raynaud phenomenon | 152 (62.6) |
| Nephropathy | 34 (14.0) |
| Dialysis | 4 (1.6) |
| Hypocomplementaemia | 139 (57.2) |
| Anti-dsDNA (+) | 87 (35.8) |
| Thrombocytopenia | 8 (3.3) |
| Leucopenia | 14 (5.8) |
| Anaemia | 105 (43.2) |
SLE, systemic lupus erythematosus; SLE-DAS, Systemic Lupus Erythematosus-Disease Activity Score.
Simple and multiple linear regression analyses of factors associated with the intimate relationships domain of the LupusQoL in female patients with systemic lupus erythematosus
| Variable | Simple linear regression | Multiple linear regression | ||||
| β (95% CI) | Std β | P value | β (95% CI) | Std β | P value | |
| Age interval (years) | ||||||
| ≥40 | Ref | Ref | ||||
| 20‒39 | 24.02 (16.04 to 32.00) | 0.36 | <0.001 | 14.52 (6.33 to 22.71) | 0.22 | 0.001 |
| Body mass index (kg/m2) | ||||||
| Normal (≥18.5 and <24.0) | Ref | |||||
| Other | 0.52 (−7.85 to 8.90) | 0.01 | 0.902 | |||
| Educational level | ||||||
| High school or below | Ref | Ref | ||||
| College or above | 24.29 (16.51 to 32.07) | 0.37 | <0.001 | 11.64 (3.51 to 19.76) | 0.18 | 0.005 |
| Marital status | ||||||
| Married | Ref | |||||
| Single, widowed, divorced | 16.44 (7.62 to 25.25) | −0.26 | <0.001 | |||
| Employment status | ||||||
| Unemployed | Ref | Ref | ||||
| Employed | 28.75 (20.63 to 36.87) | 0.41 | <0.001 | 19.48 (11.33 to 27.62) | 0.28 | <0.001 |
| Job change related to SLE | −7.55 (−14.91 to −0.19) | −0.13 | 0.044 | |||
| Self-report health status | ||||||
| Not healthy | Ref | Ref | ||||
| Healthy | 14.19 (5.05 to 23.33) | 0.19 | 0.002 | 10.25 (2.26 to 18.23) | 0.14 | 0.012 |
| Smoking habit | −5.64 (−21.60 to 10.32) | −0.04 | 0.487 | |||
| Alcohol use | 7.51 (−2.20 to 17.22) | 0.10 | 0.129 | |||
| Regular exercise | 7.17 (−4.19 to 18.53) | 0.08 | 0.215 | |||
| Length of sleep, hours | ||||||
| ≥8 | Ref | |||||
| ≤7 | 0.30 (−11.10 to 11.70) | 0.003 | 0.958 | |||
| Sleeping medication use | −17.57 (−26.71 to −8.43) | −0.24 | <0.001 | |||
| Age at diagnosis, years | ||||||
| ≥30 | Ref | |||||
| ≤29 | 20.83 (12.81 to 28.85) | 0.31 | <0.001 | |||
| Disease duration, years | ||||||
| ≥10 | Ref | |||||
| ≤9 | 3.86 (−5.02 to 12.75) | 0.06 | 0.393 | |||
| SLE-DAS | −0.45 (−0.91 to 0.02) | −0.12 | 0.060 | −0.66 (−1.16 to −0.16) | −0.14 | 0.010 |
| Arthritis | −10.88 (−20.85 to −0.91) | −0.14 | 0.033 | |||
| Malar rash | 3.49 (−9.04 to 16.02) | 0.04 | 0.584 | |||
| Photosensitivity | −4.38 (−12.74 to 3.97) | −0.07 | 0.302 | |||
| Discoid rash | −24.17 (−70.37 to 22.03) | −0.07 | 0.304 | |||
| Alopecia | −10.95 (−23.98 to 2.08) | −0.11 | 0.099 | |||
| Oral ulcer | −9.61 (−21.92 to 2.70) | −0.10 | 0.125 | |||
| Vasculitis (Skin) | −2.62 (−27.63 to 22.39) | −0.01 | 0.837 | |||
| Sjögren's syndrome | −13.19 (−22.54 to −3.84) | −0.18 | 0.006 | |||
| Raynaud phenomenon | −2.96 (−11.60 to 5.67) | −0.04 | 0.500 | |||
| Nephropathy | 4.62 (−7.43 to 16.66) | 0.05 | 0.451 | |||
| Dialysis | 13.76 (−19.08 to 46.59) | 0.05 | 0.410 | |||
| Hypocomplementaemia | 5.35 (−3.08 to 13.77) | 0.08 | 0.213 | |||
| Anti-dsDNA (+) | 7.20 (−1.48 to 15.88) | 0.10 | 0.104 | |||
| Thrombocytopaenia | 18.84 (−4.49 to 42.16) | 0.10 | 0.113 | |||
| Leucopenia | 2.04 (−15.91 to 19.99) | 0.01 | 0.823 | |||
| Anaemia | 0.34 (−8.10 to 8.79) | 0.01 | 0.936 | |||
LupusQoL, Lupus Quality of Life questionnaire; SLE-DAS, Systemic lupus erythematosus disease activity score; Std β, standardised beta coefficient.
Simple and multiple linear regression analyses of the intimate relationships domain associated with the other seven domains of the LupusQoL in female patients with systemic lupus erythematosus
| Domain of LupusQoL (except the intimate relationships) | Simple linear regression | Multiple linear regression* | ||||
| β (95% CI) | Std β | P value | β (95% CI) | Std β | P value | |
| Physical health | 0.82 (0.61 to 1.03) | 0.45 | <0.001 | 0.24 (0.002 to 0.48) | 0.13 | 0.048 |
| Emotional health | 0.66 (0.45 to 0.88) | 0.37 | <0.001 | |||
| Body image | 0.42 (0.24 to 0.59) | 0.29 | <0.001 | |||
| Pain | 0.49 (0.34 to 0.64) | 0.38 | <0.001 | |||
| Planning | 0.49 (0.32 to 0.66) | 0.35 | <0.001 | |||
| Fatigue | 0.52 (0.35 to 0.68) | 0.37 | <0.001 | 0.25 (0.07 to 0.43) | 0.18 | 0.006 |
| Burden to others | 0.42 (0.29 to 0.56) | 0.36 | <0.001 | 0.23 (0.09 to 0.38) | 0.20 | 0.002 |
*Adjusted for age interval, educational level, self-report health status, SLE-DAS and employment status.
LupusQoL, Lupus Quality of Life questionnaire; SLE-DAS, Systemic Lupus Erythematosus-Disease Activity Score; Std β, standardised beta coefficient.